跳至主要内容
临床试验/IRCT2015091323989N1
IRCT2015091323989N1已完成4 期

Effects of cholecalciferol supplementation on Bone mineral metabolism in end stage renal disease patients in comparison with placebo

ephrology Department, Shaikh Zayad Hospital0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Age more than 18 years
  • On hemodialysis thrice per week for more than 3 months
  • Both the gender
  • Patients who give informed consents
  • Exclusion criteria:
  • The patients with history of active bleeding (melena, hematemesis, hematochezia).
  • Patients who have taken cholecalceferol or ergocholicalciferol within two months period,
  • Patients taking cinacalcet
  • Iv Iron in 1 month prior to enrollment
  • Blood transfusion 1month prior to enrollment during the study
  • Any diagnosed malignancy, tubercular infection, sarcoidosis, pregnancy
  • Calcitriol or active vitamin D3 or erythropoietin dosage adjustment 1 month prior to enrollment
  • Patients having corrected serum calcium>10.2 mg/dl or having serum phosphorus >6mg/dl

排除标准

  • 未提供

研究者

发起方
ephrology Department, Shaikh Zayad Hospital

相似试验